A detailed history of Advisor Group Holdings, Inc. transactions in Omeros Corp stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 200 shares of OMER stock, worth $1,776. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200
Previous 200 -0.0%
Holding current value
$1,776
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$2.88 - $4.89 $676 - $1,149
-235 Reduced 54.02%
200 $0
Q4 2023

Feb 12, 2024

SELL
$1.08 - $3.63 $9,285 - $31,210
-8,598 Reduced 95.18%
435 $1,000
Q3 2023

Nov 13, 2023

BUY
$2.81 - $5.69 $11,619 - $23,528
4,135 Added 84.42%
9,033 $26,000
Q2 2023

Aug 10, 2023

SELL
$4.45 - $7.57 $47,668 - $81,089
-10,712 Reduced 68.62%
4,898 $26,000
Q1 2023

May 12, 2023

BUY
$2.48 - $5.22 $12,400 - $26,100
5,000 Added 47.13%
15,610 $72,000
Q4 2022

Feb 10, 2023

SELL
$1.75 - $3.96 $21,162 - $47,888
-12,093 Reduced 53.27%
10,610 $23,000
Q3 2022

Nov 14, 2022

BUY
$3.09 - $7.46 $6,467 - $15,613
2,093 Added 10.16%
22,703 $72,000
Q2 2022

Aug 10, 2022

BUY
$1.92 - $6.28 $38,784 - $126,856
20,200 Added 4926.83%
20,610 $57,000
Q1 2022

May 04, 2022

SELL
$5.07 - $7.2 $24,690 - $35,064
-4,870 Reduced 92.23%
410 $2,000
Q3 2021

Nov 05, 2021

SELL
$13.4 - $16.3 $13,400 - $16,300
-1,000 Reduced 15.92%
5,280 $72,000
Q2 2021

Aug 02, 2021

BUY
$14.81 - $19.13 $84,417 - $109,041
5,700 Added 982.76%
6,280 $94,000
Q1 2021

May 13, 2021

BUY
$14.52 - $23.53 $4,356 - $7,059
300 Added 107.14%
580 $10,000
Q1 2020

May 18, 2020

BUY
$9.03 - $19.72 $2,528 - $5,521
280 New
280 $3,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $557M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.